Reimbursed Care Access in Belarus

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Evidence from country overviews and civil‑society reporting indicates psilocybin (and psilocybin‑containing preparations) are treated as narcotics under Belarusian law and subject to heavy criminal penalties. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Belarusian criminal code and the national lists for controlled narcotics treat MDMA and related substituted amphetamines as prohibited; there is no public framework for medical/insured MDMA‑assisted therapy. # #

There is no verifiable public evidence of a national marketing authorisation or an established, reimbursed esketamine (Spravato) treatment programme in Belarus. Esketamine (Spravato) is authorised in the EU under a restricted distribution and supervised‑use model, but that European authorisation does not confer Belarusian national registration; Belarusian registration of medicinal products is governed by national registration/clinical trial procedures and the national expertise centre. Therefore, esketamine is not known to be available as a reimbursed, standard treatment in Belarus and would only be accessible via formal clinical trials or an individual import/compassionate‑use pathway if permitted and approved locally. # # #

Ketamine is an established, registered medicinal anaesthetic and analgesic used in Belarusian medical settings (primarily as an anaesthetic and emergency analgesic). Its medical/anaesthetic use is part of standard hospital formularies and governed by national medicine registration and hospital practice; ketamine preparations and injectable formulations are listed in regional pharmaceutical reference databases used in the post‑Soviet region. However, there is no documented, nationally funded or reimbursed programme in Belarus for ketamine as a licensed psychiatric or psychedelic therapy (e.g., for treatment‑resistant depression) comparable to esketamine programmes in other jurisdictions. Off‑label psychiatric use would therefore be limited, institutionally determined, and unlikely to be covered by public reimbursement absent explicit national guidance. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Publicly available country law reviews and legal guides treat DMT as illegal in Belarus and subject to the same punitive approach applied to other powerful tryptamines. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public legal pathway in Belarus for clinical administration or reimbursement of 5‑MeO‑DMT. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no recognized medical/insured ibogaine treatment programme in Belarus. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Preparations containing DMT (the active alkaloid in ayahuasca) fall under national narcotics control; there is no legal framework for ritual/religious exemptions or reimbursed therapeutic use in Belarus. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline and mescaline‑containing cacti are treated as prohibited substances under the national approach to psychoactive drugs. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Synthetic phenethylamines in the 2C family are encompassed by Belarus's broadly punitive drug control regime. # #